Blogs
News
-
Collaborations | 26 Jun, 2026
Porton Advanced Powers Qihan Biotech’s Second FDA IND Approval for Allogeneic Dual-Targeting CAR-T Product
-
Collaborations | 28 May, 2026
China-US Dual Filing Success:Porton Advanced’s End-to-End Bacterial Vector CDMO Solution Accelerates NMPA Approval of Salvectors’ Innovative Oncolytic Bacteria Therapy












